COM_RESEARCHSTUDIES_DETAIL_AVAL_STATUS_4

Study of RGX-202-01 w/ or w/o FOLFIRI in Patients with Advanced Colorectal Cancer

To evaluate the safety and efficacy of RGX-202-01 alone and in combination with 5-fluorouracil and leucovorin plus irinotecan

Age & Gender

18 years ~ 99 years
Male, Female

Contact the Team

Location

COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Hanna Sanoff
Medicine- Oncology

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Colorectal, Pancreatic, Stomach and Esophageal, Other Cancers)

IRB Number

18-2275

ClinicalTrials.gov

NCT03597581

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.